HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Matthias Roth Oliver Reuthebuch Erwin P. Bauer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roth, M. Articles by Bauer, E. P. Search for Related Content PubMed PubMed Citation Articles by Roth, M. Articles by Bauer, E. P.

J Thorac Cardiovasc Surg 2000;120:642-650
© 2000 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: A randomized, double-blind study

From the Departments of Thoracic and Cardiovascular Surgery^a and Anesthesiology,^b Kerckhoff-Clinic Foundation, Bad Nauheim, and the Department of Cardiology,^c Heart Center Baden, Lahr, Germany.

Address for reprints: Matthias Roth, MD, Department of Thoracic and Cardiovascular Surgery, Kerckhoff-Clinic Foundation, Benekestr 2-8, 61231 Bad Nauheim, Germany (E-mail: Matthias.Roth{at}kerckhoff.med.uni-giessen.de).

Background: The propensity for leukocytes to cause reperfusion injury in patients undergoing heart surgery is widely accepted. Reperfusion injury may result in myocardial damage and unfavorable operative outcome, especially in patients with severely reduced ejection fractions. This study was performed to evaluate the impact of leukocyte filtration on the postoperative course of patients undergoing coronary bypass surgery.
Methods: Thirty-two patients with coronary artery disease and left ventricular ejection fraction less than 35% were included in this double-blind, randomized study. Two serial leukocyte removal filters (Pall BC1B filter [Pall Biomedical, Portsmouth, England], group F, 15 patients) or two dummy filters (group C, 17 patients) were connected to the blood cardioplegia line. Leukocyte count, hemodynamic measurement, and transesophageal echocardiography were performed before and after cardiopulmonary bypass. Cardiac-specific enzymes were analyzed from arterial blood during the first 72 hours and from coronary sinus blood 30 and 60 minutes after aortic unclamping.
Results: Patient characteristics were similar in the two groups (ejection fraction 20.9% ± 4.3% in group C and 21.1% ± 4.8% in group F; P = .773). No early death or perioperative myocardial infarction occurred. Leukocyte count, hemodynamic parameters, cardiac troponin T, cardiac troponin I, and creatine kinase MB mass levels in arterial blood were similar in the two groups. Group F showed lower release of cardiac troponin T from the coronary sinus 30 minutes after unclamping of the aorta (group F, 0.263 ± 0.12 ng/mL; group C, 0.6 ± 0.32 ng/mL; P = .005). Lower doses of dopamine were necessary after cardiopulmonary bypass (group F, 0.36 ± 0.11 mg · kg^–1 · min^–1; group C, 0.49 ± 0.14 mg · kg^–1 · min^–1; P = .003). A moderate increase in ejection fraction was observed at 30 minutes in both groups (group F, 30.3% ± 6.2%; group C, 28.0% ± 6.3%; P = .239) and a significant increase at 60 minutes in group F (group F, 32.5% ± 6.0%; group C, 27.4% ± 7.5%; P = .012).
Conclusions: These results indicate that serial leukocyte filters connected to the blood cardioplegia line decrease myocardial cell injury and may therefore help to improve outcome of patients with severely depressed ejection fractions undergoing coronary artery bypass grafting.

This article has been cited by other articles:

				S. Gunaydin, K. Ayrancioglu, E. Dikmen, K. Mccusker, V. Vijay, T. Sari, T. Tezcaner, and Y. Zorlutuna Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts Perfusion, July 1, 2007; 22(4): 279 - 288. [Abstract] [PDF]

				O. Warren, C. Alexiou, R. Massey, D. Leff, S. Purkayastha, J. Kinross, A. Darzi, and T. Athanasiou The effects of various leukocyte filtration strategies in cardiac surgery Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 665 - 676. [Abstract] [Full Text] [PDF]

				D. C Whitaker, J. Stygall, M. J. Harrison, I. J Mackie, M. Kemp, J. Hooper, W. B Pugsley, and S. P Newman Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation Perfusion, January 1, 2006; 21(1): 55 - 60. [Abstract] [PDF]

				S. G Raja and G. D Dreyfus Modulation of Systemic Inflammatory Response after Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395. [Abstract] [Full Text] [PDF]

				R. F. Salamonsen, J. Anderson, M. Anderson, M. Bailey, G. Magrin, and F. Rosenfeldt Total Leukocyte Control for Elective Coronary Bypass Surgery Does Not Improve Short-Term Outcome Ann. Thorac. Surg., June 1, 2005; 79(6): 2032 - 2038. [Abstract] [Full Text] [PDF]

				A J de Vries, Y J Gu, and W van Oeveren Leucocyte filtration of residual heart-lung machine blood in children undergoing congenital heart surgery Perfusion, December 1, 2004; 19(6): 345 - 349. [Abstract] [PDF]

				K. Yamazaki, S. Miwa, K. Ueda, S. Tanaka, S. Toyokuni, O. Unimonh, K. Nishimura, and M. Komeda Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 270 - 275. [Abstract] [Full Text] [PDF]

				G. M. Palatianos, G. Balentine, E. G. Papadakis, C. D. Triantafillou, M. I. Vassili, A. Lidoriki, A. Dinopoulos, and G. M. Astras Neutrophil depletion reduces myocardial reperfusion morbidity Ann. Thorac. Surg., March 1, 2004; 77(3): 956 - 961. [Abstract] [Full Text] [PDF]

				A. J. Chong, C. R. Hampton, and E. D. Verrier Microvascular Inflammatory Response in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 333 - 354. [Abstract] [PDF]

				J. Martin, G. Lutter, C. Ihling, M. Siepe, S. Wagner, J. Hilberath, M. Kemper, K. Sarai, and F. Beyersdorf Myocardial viability twenty-four hours after orthotopic heart transplantation from non-heart-beating donors J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1217 - 1228. [Abstract] [Full Text] [PDF]

				P. Samankatiwat, I. Samartzis, P. Lertsithichai, D. Stefanou, P. P Punjabi, K. M Taylor, and T. Gourlay Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies Perfusion, March 1, 2003; 18(2): 95 - 105. [Abstract] [PDF]

				G. D. Buckberg Endothelial and myocardial stunning J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S92 - 93. [Full Text] [PDF]

				J. Martin, M. Krause, C. Benk, G. Lutter, M. Siegenthaler, and F. Beyersdorf Blood cardioplegia filtration Perfusion, January 1, 2003; 18(1_suppl): 75 - 80. [Abstract] [PDF]

				G Matheis, M Scholz, A Simon, O. Dzemali, and A Moritz Leukocyte filtration in cardiac surgery: a review Perfusion, September 1, 2001; 16(5): 361 - 370. [Abstract] [PDF]

				S J Morris Leukocyte reduction in cardiovascular surgery Perfusion, September 1, 2001; 16(5): 371 - 380. [PDF]

				G. D. Buckberg Editorial: Endothelial and myocardial stunning J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 640 - 641. [Full Text] [PDF]